US 7,732,131 B2 · Therapeutic and diagnostic methods and compositions targeting 4Ig-B7-H3 and its counterpart NK cell receptor

Abstract

The present invention relates to the identification of 4Ig-B7-H3 protein as a tumor associated molecule that imparts protection from NK cell-mediated lysis via a 4Ig-B7-H3 receptor on NK cells. The invention provides compounds that interfere with interactions between the 4Ig-B7-H3 protein and its receptor that can be used to potentiate NK cell cytotoxicity. Also provided are compounds that bind 4Ig-B7-H3-expressing cells so as to inhibit or eliminate them. The compounds are particularly useful in the treatment of tumors, inflammatory conditions, infections and transplantation. Also provided are methods for diagnosing disease by detecting a 4Ig-B7-H3 protein.

Claims1

Dependent claims

A method of screening compounds comprising:

a) providing a purified population of natural killer (NK) cells and a candidate compound;
b) contacting said purified population of NK cells with said candidate compound;
and
c) assaying said contacted population of NK cells for activation against a target cell expressing a 4Ig-B7-H3 polypeptide comprising SEQ ID NO:
2, wherein activation of NK cells in said population of NK cells indicates that the candidate compound inhibits the binding of said 4Ig-B7-H3 polypeptide to said NK cells.

2 more elements

Dependencies are inferred from the claim text.

Facts

Application

11/659,175Filed 2 Aug 2005 · us provisional application

Priority

3 Aug 2004

Published

US 2008/0081346 A13 Apr 2008

Granted

8 Jun 2010

Term ends

Not estimatedThe source records don’t support an estimate.

Classification13 codes

A61K 39/39558
Against materials from animals: against tumor tissues, cells, antigens
A61P 29/00
Non-central analgesic, antipyretic or antiinflammatory agents
A61P 31/00
Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
A61P 35/00
Antineoplastic agents

Therapeutic and diagnostic methods and compositions targeting 4Ig-B7-H3 and its counterpart NK cell receptor

Life of this patent

Therapeutic and diagnostic methods and compositions targeting 4Ig-B7-H3 and its counterpart NK cell receptor

Life of this patent

Abstract

Claims1